In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Probitas Pharma SA

www.grifols.com

Latest From Probitas Pharma SA

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.

Deal Statistics Quarterly, Q3 2001

In Vivo presents another installment of our quarterly review of dealmaking--in this case July 2001-September 2001. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Grupo Grifols
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Spain
  • Parent & Subsidiaries
  • Probitas Pharma SA
  • Senior Management
  • Victor Grifols, Pres.
  • Contact Info
  • Probitas Pharma SA
    Phone: (34) 3 4174 208
    Jesus Y Maria 6
    Barcelona,
    Spain
Advertisement
Advertisement
UsernamePublicRestriction

Register